Aside from this compound, no small molecules have been developed as HSP27 inhibitors for cancer therapy, although functional HSP27 inhibition may be a good strategy for combination therapy with HSP90 inhibitors, chemotherapeutic agents, or radiation. This evidence concerns the gene HSP90AA1 and cancer.